BioStem Technologies, Inc. (BSEM)
4.15
+0.27
(+6.96%)
USD |
NASDAQ |
Sep 25, 16:00
4.08
-0.07
(-1.69%)
After-Hours: 18:08
BioStem Technologies Cash from Operations (TTM) : -5.919M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.919M |
| March 31, 2026 | 5.042M |
| December 31, 2025 | 9.941M |
| September 30, 2025 | 15.26M |
| June 30, 2025 | 27.06M |
| March 31, 2025 | 27.98M |
| December 31, 2024 | 24.46M |
| September 30, 2024 | 14.89M |
| June 30, 2024 | 5.024M |
| March 31, 2024 | -2.280M |
| December 31, 2023 | -3.499M |
| September 30, 2023 | -2.519M |
| June 30, 2023 | -2.385M |
| March 31, 2023 | -0.958M |
| December 31, 2022 | 0.3036M |
| September 30, 2022 | 0.7947M |
| June 30, 2022 | 1.027M |
| March 31, 2022 | 1.632M |
| December 31, 2021 | -0.1095M |
| September 30, 2021 | -0.6202M |
| Date | Value |
|---|---|
| June 30, 2021 | -0.711M |
| March 31, 2021 | -2.185M |
| December 31, 2020 | -1.013M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -3.580M |
| December 31, 2018 | -3.660M |
| September 30, 2018 | -2.915M |
| June 30, 2018 | -1.860M |
| March 31, 2018 | -1.717M |
| December 31, 2017 | -1.646M |
| September 30, 2017 | -2.743M |
| June 30, 2017 | -2.37M |
| March 31, 2017 | -1.947M |
| December 31, 2016 | -1.694M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Filana Therapeutics, Inc. | -28.70M |
| CorMedix, Inc. | 253.62M |
| Eloxx Pharmaceuticals, Inc. | -- |
| Breakthrough Chemistry, Inc. | -0.0066M |
| Cardiac Biotech Solutions, Inc. | -0.6874M |